bioAffinity Technologies, Inc. (BIAF) Financials
BIAF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 7.6 million | 3.9 million |
| March 31, 2026 | 7.9 million | 4.3 million |
| Dec. 31, 2025 | 11.0 million | 3.7 million |
| Sept. 30, 2025 | 11.5 million | 2.6 million |
BIAF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -3.3 million | 784941 |
| March 31, 2026 | -3.2 million | 14340 |
| Dec. 31, 2025 | -2.5 million | -605355 |
| Sept. 30, 2025 | -2.5 million | 67132 |
BIAF Net Income
No data available :(
BIAF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 2.4 million | 36465 | 1.1 million |
| March 31, 2026 | 3.1 million | 38915 | 1.1 million |
| Dec. 31, 2025 | 6.4 million | 41313 | 1.0 million |
| Sept. 30, 2025 | 7.7 million | 43658 | 500894 |
BIAF Shares Outstanding
BIAF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 89966 | 361575 | 2.9 million | - |
| March 31, 2026 | 5660 | 349707 | 3.2 million | - |
| Dec. 31, 2025 | 60565 | 668813 | 3.0 million | - |
| Sept. 30, 2025 | 3648 | 473900 | 2.2 million | - |
BIAF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 1.5 million | 4.8 million |
| March 31, 2026 | 1.4 million | 1.0 million |
| Dec. 31, 2025 | 1.6 million | 1.3 million |
| Sept. 30, 2025 | 1.4 million | 1.1 million |
BIAF Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BIAF
Price: $15.27
52 week price:
Earnings Per Share: -1.35 USD
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 6.4 million